Abstract:Due to the increasing prevalence of life-threatening bacterial, fungal and viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compunds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable compounds for this task are usually derived from natural sources (animal, plant or even microbial). In this review article, the latest and most promising natural compounds used to combat bacteria, filamentous fungi and viruses are presented and evaluated. These include plant extracts, essential oils, small antimicrobial peptides of animal origin, bacteriocins and various groups of plant compounds (triterpenoids; alkaloids; phenols; flavonoids) with antimicrobial and antiviral activity. Data are presented on the inhibitory activity of each natural antimicrobial substance and on the putative mechanism of action against bacterial and fungal strains. The results show that among the bioactive compounds studied, triterpenoids have significant inhibitory activity against coronaviruses, but flavonoids have also been shown to inhibit SARS-COV-2. The last chapter is devoted to nanocarriers used to improve stability, bioavailability, cellular uptake/internalization, pharmacokinetic profile and reduce toxicity of natural compunds. There are a number of nanocarriers such as liposomes, drug delivery microemulsion systems, nanocapsules, solid lipid nanoparticles, polymeric micelles, dendrimers, etc. However, some of the recent studies have focused on the incorporation of natural substances with antimicrobial/antiviral activity into polymeric nanoparticles, niosomes and silver nanoparticles (which have been shown to have intrinsic antimicrobial activity). The natural antimicrobials isolated from animals and microorganisms have been shown to have good inhibitory effect on a range of pathogens, however the plants remain the most prolific source. Even if the majority of the studies for the biological activity evaluation are in silico or in vitro , their internalization in the optimum nanocarriers represents the future of “green therapeutics” as shown by some of the recent work in the field.

Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use

Recent Research Progress: Discovery of Anti-Plant Virus Agents Based on Natural Scaffold

Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens

VFDB 2025: an integrated resource for exploring anti-virulence compounds

Novel Antibacterial Modalities Against Methicillin Resistant Staphylococcus Aureus Derived from Plants

Plant Natural Flavonoids Against Multidrug Resistant Pathogens

Antimicrobial potentials of natural products against multidrug resistance pathogens: a comprehensive review

Progress in the development and application of plant-based antiviral agents

Inhibitory mechanisms of promising antimicrobials from plant byproducts: A review.

Plant-Derived Antimicrobials and Their Crucial Role in Combating Antimicrobial Resistance

Use of Plant Extracts, Bee-Derived Products, and Probiotic-Related Applications to Fight Multidrug-Resistant Pathogens in the Post-Antibiotic Era

Natural Compounds With Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation

Therapeutic and Unconventional Strategies to Contrast Antimicrobial Resistance: A Literature Review

Natural products as potential lead compounds to develop new antiviral drugs over the past decade

Recent perspectives on the virulent factors and treatment options for multidrug-resistant Acinetobacter baumannii

Secondary plant metabolites as potent drug candidates against antimicrobial-resistant pathogens

Antimicrobial Resistance and New Antimicrobial Agents, A Review of the Literature

Antibiotic‐producing plant‐associated bacteria, anti‐virulence therapy and microbiome engineering: Integrated approaches in sustainable agriculture

Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems

Recent progress of antibacterial natural products: Future antibiotics candidates

Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens